Case Report
Accepted on 30 Jan 2026
Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A case report
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Case Report
Accepted on 30 Jan 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 30 Jan 2026
in Public Mental Health
Original Research
Accepted on 30 Jan 2026
in Mechanisms in Allergy
Original Research
Accepted on 30 Jan 2026
in Atherosclerosis and Vascular Medicine
Case Report
Accepted on 30 Jan 2026
in Thrombosis and Haemostasis
Original Research
Accepted on 30 Jan 2026
in Food Microbiology
Mini Review
Accepted on 30 Jan 2026
in Neonatology
Original Research
Accepted on 30 Jan 2026
in Nutrition, Psychology and Brain Health
Original Research
Accepted on 30 Jan 2026
in Health Policy and Management
Perspective
Accepted on 30 Jan 2026
in Veterinary Clinical, Anatomical, and Comparative Pathology
Original Research
Accepted on 30 Jan 2026
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Jan 2026
in Implementation Science
Editorial
Accepted on 30 Jan 2026
in Sleep and Circadian Rhythms
Original Research
Accepted on 30 Jan 2026
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Jan 2026
in Functional Plant Ecology
Original Research
Accepted on 30 Jan 2026
in Biomechanics and Control of Human Movement